Site icon News Azi

Dr Reddy’s gets DCGI nod for single-shot Sputnik Light vaccine

A press release from the drug maker said Dr. Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in Russia, following its Phase-III clinical trial of the single-shot Sputnik Light vaccine in India.

Dr. Reddy’s Laboratories Ltd. on Monday announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation for COVID-19 in India.

A press release from the drug maker said Dr. Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in Russia, following its Phase-III clinical trial of the single-shot Sputnik Light vaccine in India.

Sputnik Light is a single-dose vaccine and the same as the first component — recombinant human adenovirus serotype number 26 (rAd26) — of the two-dose Sputnik V vaccine.

The standalone Sputnik Light vaccine is the latest jab to be approved by the DCGI as part of India’s national inoculation effort against COVID-19. Sputnik Light is the second COVID-19 vaccine to be made available in India by Dr. Reddy’s, reaffirming the company’s commitment to explore every avenue in the fight against the pandemic, it said.

Sputnik Light has been approved in over 30 countries around the world including Argentina, UAE, Philippines and Russia. In September 2020, Dr. Reddy’s partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and distribute the vaccine in India.

In April 2021, the DCGI granted approval to the two-dose Sputnik V vaccine for restricted use in emergency situation in India.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – admin@newsazi.com. The content will be deleted within 24 hours.
Exit mobile version